スポンサーリンク
Department Of Disease Control And Homeostasis Graduate School Of Medical Science Kanazawa University | 論文
- PJ-559 Surface Electrocardiogram Characteristics of Macro-reentry around the Mitral Annulus(PJ094,ECG/Body Surface Potential Mapping/Holter 2 (A),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PJ-526 Relationship between Lipoprotein (a) and the Plaque Morphology of the Non-infarcted Vessels in Patients with Acute Myocardial Infarction(PJ089,Atherosclerosis (Clinical/Pathophysiology) 1 (IHD),Poster Session (Japanese),The 73rd Annual Scientific M
- Changes of Matrix Metalloproteinase-9 Level Is Associated With Left Ventricular Remodeling Following Acute Myocardial Infarction Among Patients Treated With Trandolapril, Valsartan or Both
- Optimal Treatment Strategy for Patients With Paroxysmal Atrial Fibrillation : J-RHYTHM Study(Arrhythmia/Electrophysiology)
- PE-488 Efficacy of Intravenous Amiodarone Therapy in Patients with Refractory Cardiac Arrhythmias(PE082,Ventricular Arrhythmia (Clinical/Diagnosis/Treatment) (A),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese Circulation Socie
- Left Ventricular Expression of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Failing Rat Hearts
- Pharmacokinetic and pharmacodynamic analysis of cyclosporine A (CsA) to find the best single time point for the monitoring and adjusting of CsA dose using twice-daily 3-h intravenous infusions in allogeneic hematopoietic stem cell transplantation
- PJ-734 Impact of Chronic Kidney Disease on Severity of Coronary Artery Disease(PJ123,Kidney/Renal Circulation/CKD 6 (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PJ-746 Clinical Characteristics in Acute Heart Failure Syndromes Patients with and without Atrial Fibrillation : A Preliminary Report from ATTEND Registry(PJ125,Preventive Medicine/Epidemiology/Education 3 (H),Poster Session (Japanese),The 73rd Annual Sci
- PJ-331 Day and Time of Admission, Clinical Characteristics, and Outcomes in Acute Heart Failure Syndromes : A Report from the ATTEND Registry(PJ056,Preventive Medicine/Epidemiology/Education 2 (H),Poster Session (Japanese),The 73rd Annual Scientific Meeti
- 2 Refractory VT/VF, Prospective Evaluation to Differentiate Lidocaine Efficacy from Nifekalant : RELIEF Study(Late Breaking Clinical Trials I,The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- Inappropriate Analyses of Automated External Defibrillators Used During In-Hospital Ventricular Fibrillation
- Acute Effects on Signal-Averaged Electrogram Parameters and Suppressing Premature Ventricular Contractions in Single or Combined Use of Class I Antiarrhythmic Drugs
- OE-426 Macrophage Infiltration in Atria Precede the Development of Arrhythmogenic Substrates of Atrial Tachyarrhythmia in Spontaneously Hypertensive Rats(OE72,Arrhythmia, Mechanism (A),Oral Presentation (English),The 73rd Annual Scientific Meeting of The
- PE-502 Impact of Acceleration of Post-prandial Remnant Lipoprotein Clearance in Autosomal Recessive Hypercholesterolemia (ARH)(PE084,Lipid Disorders 2 (H),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese Circulation Society)
- OE-410 Long-term Effects of Dietary-lifestyle Modification at 6 months after Hospital Discharge in Patients with Acute Myocardial Infarction(OE69,ACS/AMI (Clinical/Treatment) 2 (IHD),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Ja
- PJ-233 Elevated Small Dense Low-density Lipoprotein Cholesterol to Risk Marker for Stable Coronary Heart Disease, Independent of Adiponectin and C-reactive protein(Atherosclerosis,clinical(10)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeti
- PJ-167 Remarkably High Levels of Small LDL-cholesterol in Younger Patients with Acute Coronary Syndrome and Metabolic Syndrome(Preventive medicine/Epidemiology/Education(05)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Ci
- PE-502 Not LDL-Cholesterol But Apolipoprotein A1 is an Important Risk Marker for Severe Coronary Atherosclerosis in Patients Treated with Lipid-lowering Drugs(Atherosclerosis, clinical(08)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of
- Preservation of Renal Function in Response to Cardiac Resynchronization Therapy
スポンサーリンク